Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Hair dyes penetrate the scalp very minimally, less than 1%.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

A new method improves platelet testing for heart disease patients.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Method quickly measures finasteride concentration in capsules.

A new accurate and reliable method was developed to measure Spironolactone and Hydrochlorothiazide together in medicines.

The method accurately measures vinflunine in dog plasma.

The new testosterone detection kit is accurate, cost-effective, and useful for diagnosing diseases.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Hair can be used to measure cancer-related chemicals noninvasively.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

Energy healing treatment improved L-cysteine's stability, solubility, bioavailability, and shelf-life.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Confocal Raman microscopy can effectively study drug delivery in hair follicles using pig ear models.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.